Filter posts

ICER Comes Under Renewed Scrutiny

As we enter a new and exciting era of medicine, there is an important question …

#BIOCEO18: A Bright Future

“A transformative year in medicine.” That’s how BIO President and CEO Jim Greenwood recently described …

Here We Go Again (But In a Good Way)

“We achieved the lowest drug trend since we began measuring drug trend data in 1993.” …

A Flawed Bill That Would Harm Seniors

The Medicare prescription drug program has been a remarkable success for both seniors and taxpayers, …

What's Driving Health Care Spending? Hint: Not Drug Costs.

With health care costs an important concern for many Americans, a common misperception is the …

For Today’s Hearing on the Drug Delivery System, ‘Follow The Pill’

The Senate Committee on Health, Education, Labor, and Pensions will hold a hearing this morning …

New Infographic: A Response to “A Better Deal” on Drug Pricing

The United States is the global leader in biomedical innovation, discovering more new cures than …

Trusted Law Enforcement Leaders Oppose Drug Importation

One of the leading voices emerging in the debate over drug importation is law enforcement …

ICYMI: BIO’s Jim Greenwood Outlines Safety Risks of Drug Importation

“Safe prescription drugs.” That’s what pundits and politicians almost always promise when it comes to …

Commonsense Solutions to Lower Drug Costs

With a national debate underway over drug prices, people are looking for ways to help …